| Package | de.medizininformatikinitiative.kerndatensatz.mtb |
| Type | StructureDefinition |
| Id | Id |
| FHIR Version | R4 |
| Source | https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/ImplementationGuide/mii-ig-mtb-de/https://simplifier.net/resolve?scope=de.medizininformatikinitiative.kerndatensatz.mtb@2025.0.0-ballot&canonical=https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/StructureDefinition/mii-pr-mtb-immunohistochemistry-pdl1 |
| Url | https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/StructureDefinition/mii-pr-mtb-immunohistochemistry-pdl1 |
| Version | 2024.0.0-ballot |
| Status | draft |
| Name | MII_PR_MTB_Immunohistochemistry_PDL1 |
| Title | MII PR MTB Immunohistochemistry |
| Experimental | False |
| Realm | de |
| Description | Immunhistorchemistry report |
| Type | Observation |
| Kind | resource |
No resources found
| StructureDefinition | |
https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/StructureDefinition/mii-pr-mtb-immunohistochemistry  | MII PR MTB Immunohistochemistry |
FHIR{
"resourceType" : "StructureDefinition",
"id" : "mii-pr-mtb-immunohistochemistry-pdl1",
"url" : "https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/StructureDefinition/mii-pr-mtb-immunohistochemistry-pdl1",
"version" : "2024.0.0-ballot",
"name" : "MII_PR_MTB_Immunohistochemistry_PDL1",
"title" : "MII PR MTB Immunohistochemistry",
"status" : "draft",
"publisher" : "Medizininformatik Initiative",
"contact" : [
{
"telecom" : [
{
"system" : "url",
"value" : "https://www.medizininformatik-initiative.de"
}
]
}
],
"description" : "Immunhistorchemistry report",
"fhirVersion" : "4.0.1",
"kind" : "resource",
"abstract" : false,
"type" : "Observation",
"baseDefinition" : "https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/StructureDefinition/mii-pr-mtb-immunohistochemistry",
"derivation" : "constraint",
"differential" : {
"element" : [
{
"id" : "Observation.effective[x]",
"path" : "Observation.effective[x]",
"type" : [
{
"code" : "dateTime"
}
],
"mustSupport" : true
},
{
"id" : "Observation.specimen",
"path" : "Observation.specimen",
"short" : "Probe",
"definition" : "Probe"
},
{
"id" : "Observation.component",
"path" : "Observation.component",
"slicing" : {
"discriminator" : [
{
"type" : "value",
"path" : "code"
}
],
"rules" : "open",
"description" : "Immunohistochemische Ergebnisse",
"ordered" : false
}
},
{
"id" : "Observation.component:tps-score",
"path" : "Observation.component",
"sliceName" : "tps-score",
"short" : "TPS-Score",
"definition" : "Tumor Proportion Score (TPS) - Score für PD-L1-Expression in Tumorzellen. Der TPS ist der Anteil der PD-L1-positiven Tumorzellen im Verhältnis zu den Gesamtzellen. Der TPS wird in Prozent angegeben. Ein TPS von 1% oder mehr gilt als positiv.",
"min" : 0,
"max" : "1",
"mustSupport" : true
},
{
"id" : "Observation.component:tps-score.code",
"path" : "Observation.component.code",
"patternCodeableConcept" : {
"coding" : [
{
"code" : "C184941",
"system" : "https://nih-ncpi.github.io/ncpi-fhir-ig/CodeSystem-ncit.html",
"display" : "PD-L1 Tumor Proportion Score"
}
]
},
"mustSupport" : true
},
{
"id" : "Observation.component:tps-score.value[x]",
"path" : "Observation.component.value[x]",
"slicing" : {
"discriminator" : [
{
"type" : "type",
"path" : "$this"
}
],
"ordered" : false,
"rules" : "open"
}
},
{
"id" : "Observation.component:tps-score.value[x]:valueQuantity",
"path" : "Observation.component.value[x]",
"sliceName" : "valueQuantity",
"min" : 0,
"max" : "1",
"type" : [
{
"code" : "Quantity"
}
],
"mustSupport" : true
},
{
"id" : "Observation.component:tps-score.interpretation",
"path" : "Observation.component.interpretation",
"mustSupport" : true
},
{
"id" : "Observation.component:cps-score",
"path" : "Observation.component",
"sliceName" : "cps-score",
"short" : "CPS-Score",
"definition" : "Combined Positive Score (CPS) - Score für PD-L1-Expression in Tumorzellen und Immunzellen. Der CPS ist der Anteil der PD-L1-positiven Tumorzellen und Immunzellen im Verhältnis zu den Gesamtzellen. Der CPS wird in Prozent angegeben. Ein CPS von 1% oder mehr gilt als positiv.",
"min" : 0,
"max" : "1",
"mustSupport" : true
},
{
"id" : "Observation.component:cps-score.code",
"path" : "Observation.component.code",
"patternCodeableConcept" : {
"coding" : [
{
"code" : "C176582",
"system" : "https://nih-ncpi.github.io/ncpi-fhir-ig/CodeSystem-ncit.html",
"display" : "PD-L1 Combined Positive Score"
}
]
},
"mustSupport" : true
},
{
"id" : "Observation.component:cps-score.value[x]",
"path" : "Observation.component.value[x]",
"slicing" : {
"discriminator" : [
{
"type" : "type",
"path" : "$this"
}
],
"ordered" : false,
"rules" : "open"
}
},
{
"id" : "Observation.component:cps-score.value[x]:valueQuantity",
"path" : "Observation.component.value[x]",
"sliceName" : "valueQuantity",
"min" : 0,
"max" : "1",
"type" : [
{
"code" : "Quantity"
}
],
"mustSupport" : true
},
{
"id" : "Observation.component:cps-score.interpretation",
"path" : "Observation.component.interpretation",
"mustSupport" : true
},
{
"id" : "Observation.component:ics-score",
"path" : "Observation.component",
"sliceName" : "ics-score",
"short" : "ICS-Score",
"definition" : "Immune Cell Score (ICS) - Score für PD-L1-Expression in Immunzellen. Der ICS ist der Anteil der PD-L1-positiven Immunzellen im Verhältnis zu den Gesamtzellen. Der ICS wird in Prozent angegeben. Ein ICS von 1% oder mehr gilt als positiv.",
"min" : 0,
"max" : "1",
"mustSupport" : true
},
{
"id" : "Observation.component:ics-score.code",
"path" : "Observation.component.code",
"patternCodeableConcept" : {
"coding" : [
{
"code" : "C199175",
"system" : "https://nih-ncpi.github.io/ncpi-fhir-ig/CodeSystem-ncit.html",
"display" : "Cells.programmed cell death ligand 1/Viable tumor cells in Tissue by Immune stain"
}
]
},
"mustSupport" : true
},
{
"id" : "Observation.component:ics-score.value[x]",
"path" : "Observation.component.value[x]",
"slicing" : {
"discriminator" : [
{
"type" : "type",
"path" : "$this"
}
],
"ordered" : false,
"rules" : "open"
}
},
{
"id" : "Observation.component:ics-score.value[x]:valueQuantity",
"path" : "Observation.component.value[x]",
"sliceName" : "valueQuantity",
"min" : 0,
"max" : "1",
"type" : [
{
"code" : "Quantity"
}
],
"mustSupport" : true
},
{
"id" : "Observation.component:ics-score.interpretation",
"path" : "Observation.component.interpretation",
"mustSupport" : true
},
{
"id" : "Observation.component:tc-score",
"path" : "Observation.component",
"sliceName" : "tc-score",
"short" : "TC-Score / TPS-Score",
"definition" : "Tumor Cell Score (TC-Score) - Score für PD-L1-Expression in Tumorzellen. Der TC-Score ist der Anteil der PD-L1-positiven Tumorzellen im Verhältnis zu den Gesamtzellen. Der TC-Score wird in Prozent angegeben. Ein TC-Score von 1% oder mehr gilt als positiv.",
"min" : 0,
"max" : "1",
"mustSupport" : true
},
{
"id" : "Observation.component:tc-score.code",
"path" : "Observation.component.code",
"patternCodeableConcept" : {
"coding" : [
{
"code" : "83053-9",
"system" : "http://loinc.org",
"display" : "Cells.programmed cell death ligand 1/Viable tumor cells in Tissue by Immune stain"
}
]
},
"mustSupport" : true
},
{
"id" : "Observation.component:tc-score.value[x]",
"path" : "Observation.component.value[x]",
"slicing" : {
"discriminator" : [
{
"type" : "type",
"path" : "$this"
}
],
"ordered" : false,
"rules" : "open"
}
},
{
"id" : "Observation.component:tc-score.value[x]:valueQuantity",
"path" : "Observation.component.value[x]",
"sliceName" : "valueQuantity",
"min" : 0,
"max" : "1",
"type" : [
{
"code" : "Quantity"
}
],
"mustSupport" : true
},
{
"id" : "Observation.component:tc-score.interpretation",
"path" : "Observation.component.interpretation",
"mustSupport" : true
}
]
},
"text" : {
}
}
XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.